-
Groundbreaking Acquisition: Gilead Introduces IL-12 Anti-Tumor Therapy
In a groundbreaking move, Gilead Sciences has announced its exclusive licensing agreement with Xilio Therapeutics to jointly develop and commercialize...
2024-04-02 14:53 -
Unveiling China's Innovation Pharmaceutical Industry: A Year of Unprecedented Growth
The year 2023 proved to be a defining period for China's innovation pharmaceutical industry, marked by remarkable achievements and valuable insights.
2024-04-02 14:51 -
Key Pharmaceutical Companies Incyte and CMS Pharmaceutical Holdings Collaborate on Oral JAK1 Inhibit...
Incyte and CMS Pharmaceutical Holdings have entered into a strategic collaboration and licensing agreement for the development and commercialization o...
2024-04-02 14:44 -
The Dawn of Artificial Intraocular Lenses - A Visionary Breakthrough
Artificial intraocular lenses (IOLs) have emerged as a groundbreaking solution for several vision-related conditions, including cataracts, glaucoma, a...
2024-04-02 14:34 -
Pfizer's Dominance in the ADC Landscape: Leading the Market with a Plethora of Approved ADC Products
This article explores Pfizer's journey in the ADC landscape and highlights its key contributions to this innovative therapeutic approach.
2024-04-01 16:09 -
Pharmaceutical M&A Trends: Top 10 Acquisitions in Q1 2024
In the rapidly evolving pharmaceutical industry, mergers and acquisitions (M&A) play a crucial role in shaping the competitive landscape.
2024-04-01 16:08 -
Allegations Resurface, Placing WuXi AppTec in Hot Waters Again
In recent developments, WuXi AppTec, a leading Chinese pharmaceutical and biotechnology company, finds itself embroiled in controversy once more.
2024-04-01 16:06 -
Milestone Achievement in AI Pharmaceutical Commercialization: First Profitable Company Emerges
The field of AI pharmaceuticals has reached a significant milestone with the emergence of the first profitable company.
2024-04-01 16:04 -
Novo Nordisk's Strategic Moves in Cardiovascular Therapeutics: A Promising Future
Novo Nordisk, one of Europe's leading pharmaceutical companies, is making significant strides in the field of cardiovascular therapeutics.
2024-04-01 16:02 -
Breakthrough in Psoriasis Treatment: Hengrui Pharmaceuticals' Novel Class 1 Drug Approved for Clinic...
In a significant development for the field of dermatology, Hengrui Pharmaceuticals has received implicit approval for clinical trials of their groundb...
2024-03-29 17:35
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
- Wanhua Chemical Boosts TDI Cap... Aug 24, 2025
Related Products
Related Producers
